DIFFERENT STAKEHOLDER PERSPECTIVES ON PHARMACOGENOMIC TESTING

被引：0
|
作者：
Patel, H. [1 ]
Ursan, I [1 ]
Zueger, P. [1 ]
Pickard, A. S. [1 ]
机构：
[1] Univ Illinois, Chicago, IL USA
来源：
VALUE IN HEALTH | 2013年 / 16卷 / 03期
关键词：
D O I：
10.1016/j.jval.2013.03.1241
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A244 / A244
页数：1
相关论文
共 50 条
  • [1] Stakeholder Views on Pharmacogenomic Testing
    Patel, Haridarshan N.
    Ursan, Iulia D.
    Zueger, Patrick M.
    Cavallari, Larisa H.
    Pickard, A. Simon
    PHARMACOTHERAPY, 2014, 34 (02): : 151 - 165
  • [2] Stakeholder perspectives of the clinical utility of pharmacogenomic testing in solid organ transplantation
    Deininger, Kimberly M.
    Tran, Jacinda N.
    Tsunoda, Shirley M.
    Young, Gordon K.
    Lee, Yee Ming
    Anderson, Heather D.
    Page, Robert L., II
    Hirsch, Jan D.
    Aquilante, Christina L.
    PHARMACOGENOMICS, 2019, 20 (18) : 1291 - 1302
  • [3] Patient Perspectives of Barriers and Facilitators for the Uptake of Pharmacogenomic Testing in Veterans Affairs' Pharmacogenomic Testing for the Veterans (PHASER) Program
    Melendez, Karina
    Gutierrez-Meza, Diana
    Gavin, Kara L.
    Alagoz, Esra
    Sperber, Nina
    Wu, Rebekah Ryanne
    Silva, Abigail
    Pati, Bhabna
    Voora, Deepak
    Hung, Allison
    Roberts, Megan C.
    Voils, Corrine I.
    JOURNAL OF PERSONALIZED MEDICINE, 2023, 13 (09):
  • [4] Providers' perspectives on the clinical utility of pharmacogenomic testing in pediatric patients
    Liko, Ina
    Lee, Yee Ming
    Stutzman, Danielle L.
    Blackmer, Allison B.
    Deininger, Kimberly M.
    Reynolds, Ann M.
    Aquilante, Christina L.
    PHARMACOGENOMICS, 2021, 22 (05) : 263 - 274
  • [5] Exploring Different Stakeholder Perspectives on Bilingualism in Autism
    Howard, Katie Beatrice
    Gibson, Jenny L.
    Katsos, Napoleon
    LANGUAGES, 2024, 9 (02)
  • [6] Lung Transplant Recipients' Perspectives on Integration of Pharmacogenomic Testing to Transplant Care
    Luo, C. Y.
    Nador, R. G.
    Levy, R. D.
    Swiston, J.
    Bergeron, C.
    Partovi, N.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (06) : S1120 - S1120
  • [7] Development and testing of the Stakeholder Quality Improvement Perspectives Survey (SQuIPS)
    Fris, Eric
    Sedlock, Emily
    Etchegaray, Jason
    Ottosen, Madelene J.
    Pucio, Ronald
    Mistry, Tejal
    Saunders, Tamara
    Tomoaia-Cotisel, Andrada
    Thomas, Eric J.
    BMJ OPEN QUALITY, 2021, 10 (04)
  • [8] Stakeholder Perspectives on a Risk-Benefit Framework for Genetic Testing
    Roth, Joshua A.
    Garrison, Louis P., Jr.
    Burke, Wylie
    Ramsey, Scott D.
    Carlson, Rick
    Veenstra, David L.
    PUBLIC HEALTH GENOMICS, 2011, 14 (02) : 59 - 67
  • [9] Non-interventional cardiologists' perspectives on the role of pharmacogenomic testing in cardiovascular medicine
    Deininger, Kimberly M.
    Page, Robert L., II
    Lee, Yee Ming
    Kauffman, Yardlee S.
    Johnson, Samuel G.
    Oreschak, Kris
    Aquilante, Christina L.
    PERSONALIZED MEDICINE, 2019, 16 (02) : 123 - 132
  • [10] Patient Willingness To Provide Different Types of Biological Samples for Pharmacogenomic Testing
    Loo, Tenneille T.
    Cuffe, Sinead
    Hon, Henrique
    Martin, Petra
    Brown, M. Catherine
    Alibhai, Shabbir
    Qiu, Xin
    Xu, Wei
    Liu, Geoffrey
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2013, 22 : 325 - 325
12345